Search company, investor...

Genentech - OCP Facility

Stage

Acquired Unit | Acquired

About Genentech - OCP Facility

Genentech creates, produces and markets solutions for unmet medical needs. The firm's products and services help to prevent, diagnose and treat diseases, thus enhancing people's health and quality of life. In August 2011, a clinical biologics manufacturing facility and certain process development assets of Genetech were acquired by Gilead. The valuation of a clinical biologics manufacturing facility and certain process development assets of Genetech were undisclosed. Other terms of the deal were not released.

Headquarters Location

1 DNA Way

San Francisco, California, 94080,

United States

Loading...

Loading...

Genentech - OCP Facility Frequently Asked Questions (FAQ)

  • Where is Genentech - OCP Facility's headquarters?

    Genentech - OCP Facility's headquarters is located at 1 DNA Way, San Francisco.

  • What is Genentech - OCP Facility's latest funding round?

    Genentech - OCP Facility's latest funding round is Acquired Unit.

  • Who are the investors of Genentech - OCP Facility?

    Investors of Genentech - OCP Facility include Gilead Sciences.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.